secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001140361-26-008340
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis announces retirement of two long-serving directors and appointment of Peter Reikes to board
--------------------------------------------------------------------------------

- B. Lynne Parshall and Joseph Wender retiring at end of term in June 2026 after 25+ years on the board.
- Peter N. Reikes to rejoin board effective June 4, 2026; he previously served from 2018-2021.
- Reikes most recently senior strategy advisor for ARPA-H and senior advisor to FDA.
- Both departing directors received Ionis Career Achievement Award; company thanks them.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036126008340/0001140361-26-008340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036126008340/ef20067398_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-008340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer